Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
ClinicalTrials.gov study NCT02614794. IPD Sharing: Not stated. Countries: 15. Publications: 6.
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Lo
ClinicalTrials.gov study NCT01702558. IPD Sharing: Not stated. Countries: 12. Publications: 1.
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
ClinicalTrials.gov study NCT01271725. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breas
ClinicalTrials.gov study NCT02131064. IPD Sharing: Not stated. Countries: 10. Publications: 3.
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Can
ClinicalTrials.gov study NCT01774786. IPD Sharing: Not stated. Countries: 32. Publications: 4.
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
ClinicalTrials.gov study NCT01670877. IPD Sharing: NO. Countries: 2. Publications: 3.
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT01912963. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
ClinicalTrials.gov study NCT02957968. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT02673398. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT03018080. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
ClinicalTrials.gov study NCT00436566. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03774472. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cance
ClinicalTrials.gov study NCT03674112. IPD Sharing: YES. Countries: 17. Publications: 2.
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
ClinicalTrials.gov study NCT03659136. IPD Sharing: NO. Countries: 11. Publications: 2.
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT01234337. IPD Sharing: Not stated. Countries: 23. Publications: 2.
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
ClinicalTrials.gov study NCT02040857. IPD Sharing: NO. Countries: 1. Publications: 1.
Afatinib in NSCLC With HER2 Mutation
ClinicalTrials.gov study NCT02369484. IPD Sharing: NO. Countries: 4. Publications: 3.
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Lo
ClinicalTrials.gov study NCT02091960. IPD Sharing: YES. Countries: 6. Publications: 1.
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00542451. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
ClinicalTrials.gov study NCT01942135. IPD Sharing: YES. Countries: 17. Publications: 23.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.